304 related articles for article (PubMed ID: 25800274)
21. T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.
Ferraz R; Cunha CF; Pimentel MI; Lyra MR; Schubach AO; Mendonça SC; Da-Cruz AM; Bertho AL
Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):596-605. PubMed ID: 26107186
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.
Herath S; Kropf P; Müller I
Parasite Immunol; 2003; 25(11-12):559-67. PubMed ID: 15053777
[TBL] [Abstract][Full Text] [Related]
23. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
24. Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major.
Crosby EJ; Clark M; Novais FO; Wherry EJ; Scott P
J Immunol; 2015 Oct; 195(7):3301-10. PubMed ID: 26290604
[TBL] [Abstract][Full Text] [Related]
25. Permissive and protective roles for neutrophils in leishmaniasis.
Carlsen ED; Liang Y; Shelite TR; Walker DH; Melby PC; Soong L
Clin Exp Immunol; 2015 Nov; 182(2):109-18. PubMed ID: 26126690
[TBL] [Abstract][Full Text] [Related]
26. Innate immune response: ally or enemy in cutaneous leishmaniasis?
Serrano-Coll H; Cardona-Castro N; Ramos AP; Llanos-Cuentas A
Pathog Dis; 2021 Jun; 79(5):. PubMed ID: 34037758
[TBL] [Abstract][Full Text] [Related]
27. Chemokines in host-parasite interactions in leishmaniasis.
Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
[TBL] [Abstract][Full Text] [Related]
28. Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.
Feijó D; Tibúrcio R; Ampuero M; Brodskyn C; Tavares N
J Immunol Res; 2016; 2016():3967436. PubMed ID: 26904694
[TBL] [Abstract][Full Text] [Related]
29. Host-Directed Therapies for Cutaneous Leishmaniasis.
Novais FO; Amorim CF; Scott P
Front Immunol; 2021; 12():660183. PubMed ID: 33841444
[TBL] [Abstract][Full Text] [Related]
30. NKT cells in leishmaniasis.
Zamora-Chimal J; Hernández-Ruiz J; Becker I
Immunobiology; 2017 Apr; 222(4):641-646. PubMed ID: 28012583
[TBL] [Abstract][Full Text] [Related]
31. T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.
Da-Cruz AM; Oliveira-Neto MP; Bertho AL; Mendes-Aguiar CO; Coutinho SG
J Invest Dermatol; 2010 May; 130(5):1329-36. PubMed ID: 20107484
[TBL] [Abstract][Full Text] [Related]
32. Immunoregulation in human American leishmaniasis: balancing pathology and protection.
Gollob KJ; Viana AG; Dutra WO
Parasite Immunol; 2014 Aug; 36(8):367-76. PubMed ID: 24471648
[TBL] [Abstract][Full Text] [Related]
33. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
[TBL] [Abstract][Full Text] [Related]
34. Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis.
Koh CC; Wardini AB; Vieira M; Passos LSA; Martinelli PM; Neves EGA; Antonelli LRDV; Barbosa DF; Velikkakam T; Gutseit E; Menezes GB; Giunchetti RC; Machado PRL; Carvalho EM; Gollob KJ; Dutra WO
Front Immunol; 2020; 11():594581. PubMed ID: 33117407
[TBL] [Abstract][Full Text] [Related]
35. Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors.
Nylén S; Maasho K; McMahon-Pratt D; Akuffo H
Scand J Immunol; 2004 Mar; 59(3):294-304. PubMed ID: 15030581
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions.
Da-Cruz AM; Bertho AL; Oliveira-Neto MP; Coutinho SG
Br J Dermatol; 2005 Sep; 153(3):537-43. PubMed ID: 16120139
[TBL] [Abstract][Full Text] [Related]
37. Imaging of the host/parasite interplay in cutaneous leishmaniasis.
Millington OR; Myburgh E; Mottram JC; Alexander J
Exp Parasitol; 2010 Nov; 126(3):310-7. PubMed ID: 20501336
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
Passelli K; Billion O; Tacchini-Cottier F
Front Immunol; 2021; 12():649348. PubMed ID: 33732265
[No Abstract] [Full Text] [Related]
39. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
[TBL] [Abstract][Full Text] [Related]
40. Depression of lymphocyte activity during cutaneous leishmaniasis: a case report.
Matera G; Torti C; Mazzitelli M; Greco G; Rania A; Peronace C; Settembre P; Galati L; Giancotti A; Lamberti AG; Barreca GS; Rossi M; Quirino A; Liberto MC; Focà A
Diagn Microbiol Infect Dis; 2018 Nov; 92(3):230-234. PubMed ID: 29950279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
